Cargando…
Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
Autores principales: | Ljung, Rickard, Pihlström, Nicklas, Sundström, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364733/ https://www.ncbi.nlm.nih.gov/pubmed/35524731 http://dx.doi.org/10.1093/bjs/znac127 |
Ejemplares similares
-
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents
por: Karlstad, Øystein, et al.
Publicado: (2022) -
Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study
por: Husby, Anders, et al.
Publicado: (2023) -
Differences by region of birth in SARS-CoV-2 vaccine coverage and positive SARS-CoV-2 test among 400 000 healthcare workers and the general population in Sweden
por: Ljung, Rickard, et al.
Publicado: (2022) -
Morphea after SARS-CoV2 vaccine()
por: Paolino, Giovanni, et al.
Publicado: (2023) -
The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)